Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer 2024-11-22 16:00
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity 2024-11-22 12:14
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology 2024-11-22 10:27
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias 2024-11-21 06:00
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products 2024-11-21 01:00
Samsung Biologics signs manufacturing deal with European pharmaceutical company 2024-11-20 07:23
Say Hello to 3.0: Datarithm Releases Latest Version of Inventory Management Solution 2024-11-19 22:00
Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA 2024-11-19 19:30
Everest Medicines Announces NEFECON® Has Received Full Approval from South Korea's Ministry of Food and Drug Safety (MFDS) for the Treatment of Primary IgA Nephropathy 2024-11-19 07:40
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline 2024-11-19 06:24
VelaVigo Announces Exclusive Option Agreement with Avenzo to License a Potential First-in-Class Nectin4/TROP2 Bispecific Antibody-Drug Conjugate 2024-11-18 21:01
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence 2024-11-18 16:00
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions 2024-11-18 09:00
Boehringer Ingelheim Commits to Veeva Vault CRM 2024-11-18 09:00
Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by CDE of China NMPA 2024-11-17 22:24
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity 2024-11-14 23:45
Continuity Biosciences Launches to Enable Breakthrough Therapies with Innovative Delivery Technologies 2024-11-13 20:30
Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology 2024-11-13 16:18
Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment 2024-11-13 13:36
Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne 2024-11-12 19:30
1 2 3 4 5 247